摘要 |
Described in the present invention is a pharmaceutical composition for treating or preventing insulin resistance syndrome such as obesity and diabetes in a mammal, which comprises an effective amount of S-adenosylmethionine as an active ingredient together with a pharmaceutically acceptable carrier. |